D W Northfelt

Summary

Country: USA

Publications

  1. ncbi request reprint Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy
    D W Northfelt
    SEQUUS Pharmaceuticals, Inc, Menlo Park, CA, USA
    J Clin Oncol 15:653-9. 1997
  2. ncbi request reprint Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial
    D W Northfelt
    University of California, San Francisco, USA
    J Clin Oncol 16:2445-51. 1998

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy
    D W Northfelt
    SEQUUS Pharmaceuticals, Inc, Menlo Park, CA, USA
    J Clin Oncol 15:653-9. 1997
    ..To determine the efficacy and safety of pegylated-liposomal doxorubicin in patients with AIDS and Kaposi's sarcoma (AIDS-KS) who experienced failure of standard chemotherapy...
  2. ncbi request reprint Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial
    D W Northfelt
    University of California, San Francisco, USA
    J Clin Oncol 16:2445-51. 1998
    ....